By February 6, 2013 Read More →

Rottenstein Law Group Encouraged by $285,000 Fosamax Lawsuit Verdict in New York

The Rottenstein Law Group, which accepts clients who wish to file Fosamax injury lawsuits, is encouraged by the Feb. 5 report of a $285,000 verdict against Merck in a New York trial over the drug Fosamax, which has been found to weaken bones and cause jaw death.

The Rottenstein Law Group, which accepts clients who wish to file Fosamax injury lawsuits, is encouraged by the Feb. 5 report of a $285,000 verdict against Merck in a New York trial over the drug Fosamax, which has been found to weaken bones and cause jaw death.

According to Reuters, the jury (In re: Scheinberg v. Merck & Co, Inc., U.S. District Court for the Southern District of New York, case no. 09-4119) found that Merck failed to warn plaintiff Rhoda Scheinberg’s doctors of potentially serious Fosamax side effects.* Scheinberg, 69, alleged that she had suffered delayed healing and disease in her jaw after a tooth extraction, both caused by Fosamax. This is the second verdict against Merck in a Fosamax trial. Previously, in a Manhattan court, a jury awarded Shirley Boles $8 million because she experienced “jaw death” while taking Fosamax, according to the story.

Read more:  Rottenstein Law Group Encouraged by $285,000 Fosamax Lawsuit Verdict in New York 


Posted in: Legal